Lumexa Imaging: Not Passing My Inspection
Summarize this article with:
The Value InvestorInvesting Group LeaderFollow5ShareSavePlay(8min)CommentsSummaryLumexa Imaging Holdings operates the second-largest outpatient diagnostic imaging network in the US with 184 centers and strong revenue growth.LMRI's IPO values the company at a $2.5 billion enterprise value, with high leverage and adjusted EBITDA multiples of 11–12x.Despite compelling growth and profitability, risks include high debt, payer mix shifts, technological change, and heavy reliance on referrals and key staff.I remain cautious due to leverage, IPO structure, and lingering questions from a roll-up story, making LMRI a pass despite reasonable headline metrics.fadfebrian/iStock via Getty Images Shares of Lumexa Imaging Holdings, Inc. (LMRI) have seen modest gains on their first day of trading, with shares trading with very modest gains. The M&A-driven growth play in diagnostic imaging services badly needed the offering proceedsThis article was written byThe Value Investor27.39K FollowersFollowThe Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events. As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capital allocation. Coverage includes 10 major events a month with an eye towards finding the best opportunities. Learn more.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Recommended For You